| First Author | Zhu Z | Year | 2020 |
| Journal | J Invest Dermatol | Volume | 140 |
| Issue | 6 | Pages | 1233-1243.e9 |
| PubMed ID | 31899186 | Mgi Jnum | J:301144 |
| Mgi Id | MGI:6502906 | Doi | 10.1016/j.jid.2019.11.022 |
| Citation | Zhu Z, et al. (2020) Aryl Hydrocarbon Receptor in Cutaneous Vascular Endothelial Cells Restricts Psoriasis Development by Negatively Regulating Neutrophil Recruitment. J Invest Dermatol 140(6):1233-1243.e9 |
| abstractText | Vascular endothelial cells (VECs) that line the interiors of blood vessels participate in physiological and inflammatory processes. All skin cell types express the aryl hydrocarbon receptor (AhR), which is involved in the pathogenesis of psoriasis. However, the role of the cutaneous VEC AhR in the pathogenesis of psoriasis remains elusive. In the present study, we found that AhR protein expression and activation were downregulated in psoriatic VECs. Furthermore, cutaneous VEC-specific AhR-knockout (AhR(cVECs-KO)) mice were established. Using imiquimod and IL-23-induced psoriasis models, we found that skin inflammation was exacerbated with excessive neutrophil recruitment in AhR(cVECs-KO) mice. Furthermore, neutrophil neutralization alleviates exacerbated inflammation in imiquimod-treated AhR(cVECs-KO) mice. In addition, cutaneous VECs in AhR(cVECs-KO) mice exhibited increased dilation and activation compared with those in control mice. Finally, AhR-deficient microvascular endothelial cells stimulated by proinflammatory cytokines showed increased ICAM-1 expression in vivo and in vitro, which may have facilitated neutrophil recruitment. In summary, our study demonstrates that AhR in dermal VECs restricts psoriasis development by negatively regulating neutrophil recruitment, thereby providing insight into the pathogenesis of psoriasis. |
